Post by
Resilience19 on Oct 13, 2020 9:25pm
When comparing with SONA...
there's no reason why DM's SP shouldn't be around $1/sh, when only factoring in the C-19 component (IMO anyways). In January SONA's SP stood roughly at 0.12, giving it a market cap of roughly $6M. Since announcing, early Feb, that they were developing C-19 tests - none of which are still cleared by FDA/HC - the SP rose as high as $16. It currently sits around $9/sh, giving SONA a mkcap of $550M(ish). Given DM has access to a breadth of (still to be FDA/HC approved) tests it would make sense, given it has already lined up a series of contracts, PO, LOI that DM's SP ait at 50%ish of SONA's valuation, which would roughly give it a $1 SP - not even factoring in DM's AI. Although SONA's rocket SP assension may not be reproduced with DM, it's rather easy to see how quickly DM's SP could also end up rising, once a larger contract (C-19 and/or AI) would be confirmed or FDA/HC test kit approval received. So, looking at DM's 0.12 SP, given recent contracts and what's in the pipeline is rather a no brainer (for me) at this time. Although we could still see the current SP stand for some time, my take is that the odds of a rapid rise, on short order, is quite realistic given current tailwind. My two cents.
Comment by
buy2009 on Oct 13, 2020 11:17pm
One small point. ONA owns their test. DM rrsells. Well not actually a small point. Since 100m tests should net SONA about 1.5B What would DM make on 100m tests? Answer: no idea
Comment by
Welderkev1 on Oct 14, 2020 2:52am
That is a very small point lol since the world is already buying DMs kits how many has sona sold?
Comment by
Jjpiz1 on Oct 14, 2020 8:33am
Sonas value lies in that it has an antigen test not a shitty antibody test. It's tech is revolutionary for c-19.
Comment by
mrmonopoly on Oct 14, 2020 9:30am
DM has an Antigen test as well which is awaiting HC approval... just like Sona. Investors over on the Sona board talk as if they are the only player in this game sometimes. Granted, I'd give Sona the edge since HC has made it perfectly clear they prefer working with actual healthcare companies. Does that justify the MC discrepancy between DM and Sona? Not even a little bit IMO.
Comment by
Jjpiz1 on Oct 14, 2020 8:05pm
Dm does not have an antigen application waiting approval with health canada. You are free to check the list. I wish they did have, I wish they even had a validation.
Comment by
ibsn4512 on Oct 14, 2020 8:19pm
Rapigen is on the list awaiting @ HC, and is Antigen. If you look at the DM website, your wish has come true!!!
Comment by
Resilience19 on Oct 14, 2020 8:56pm
Indeed @ibsn4512. Here's the June NR and further reason why DM's SP should better reflect that of SONA: COVID-19 Home Test Kits With FDA Registration TSX Venture Exchange:DM https://www.globenewswire.com/news-release/2020/06/16/2048738/0/en/DATAMETREXOBTAINSRIGHTSTOSELLCOVID-19HOMETESTKITSWITHFDAREGISTRATION.HTML.